Continued R&D investment
First written in FY2016. 19 of 34 entries say "Advanced", first in FY2018. Latest entry: FY2026.
50 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「The current R&D structure in Japan consists of 5 departments under the Development Headquarters: the Applied Development Research Department, Basic Science Research Department, Development Planning Office, Overseas Development Department and Development Administration Department. R&D expenses for the consolidated fiscal year were ¥872 million.」
R&D activities continued, including ¥872 million in Japan, ¥71 million in Southeast Asia and ¥144 million in Europe. Consolidated R&D expenses were ¥1,089 million according to the notes. - FY2026-H1AdvancedAnnual report
「The amount of R&D activities for the entire group during the current interim consolidated accounting period was ¥524 million.」
R&D expenses for the interim consolidated accounting period were ¥524 million, up from ¥460 million in the same period of the previous year. R&D activities continued. - FY2025-H1AdvancedAnnual report
「The amount of R&D activities for the entire group during the current interim consolidated accounting period was ¥474 million.」
R&D expenses for the interim consolidated accounting period were ¥474 million, up from ¥460 million in the same period of the previous year. - FY2024Decrease in R&D ExpensesAnnual report
「Total R&D expenses included in selling, general and administrative expenses and current-period manufacturing costs Previous consolidated fiscal year ¥1,034 million Current consolidated fiscal year ¥1,007 million」
Consolidated R&D expenses decreased from ¥1,034 million in the previous fiscal year to ¥1,007 million, but R&D activities continued. - FY2024-Q3Decrease in R&D ExpensesAnnual report
「The amount of R&D activities for the entire group during the third quarter of the current consolidated cumulative period was ¥549 million.」
R&D expenses for the third-quarter cumulative period were ¥549 million, down from ¥731 million in the same period of the previous year, but R&D activities continued. - FY2024-Q2Decrease in R&D ExpensesAnnual report
「The amount of R&D activities for the entire group during the second quarter of the current consolidated cumulative period was ¥358 million.」
R&D expenses for the second-quarter cumulative period were ¥358 million, down from ¥460 million in the same period of the previous year, but R&D activities continued. - FY2024-Q1AdvancedAnnual report
「The amount of R&D activities for the entire group during the first quarter of the current consolidated cumulative period was ¥246 million.」
R&D expenses for the first-quarter cumulative period were ¥246 million, up from ¥205 million in the same period of the previous year. Continued investment in R&D is progressing. - FY2023AdvancedAnnual report
「Total R&D expenses included in selling, general and administrative expenses and current-period manufacturing costs Previous consolidated fiscal year ¥993 million Current consolidated fiscal year ¥1,034 million」
Consolidated R&D expenses increased from ¥993 million in the previous fiscal year to ¥1,034 million. - FY2023-Q3Decrease in R&D ExpensesAnnual report
「The amount of R&D activities for the entire group during the third quarter of the current consolidated cumulative period was ¥731 million.」
R&D expenses for the third-quarter cumulative period were ¥731 million, down from ¥781 million in the same period of the previous year, but R&D activities continued. - FY2023-Q2RestatedAnnual report
「The amount of R&D activities for the entire group during the second quarter of the current consolidated cumulative period was ¥460 million. There were no material changes in the status of the group's R&D activities during the second quarter of the current consolidated cumulative period.」
The company reaffirmed its continued investment in R&D and the absence of material changes in its R&D activities. - FY2023-Q1AdvancedAnnual report
「Group-wide R&D expenses for the first quarter amounted to ¥205 million.」
R&D expenses for the first quarter were ¥205 million, up from ¥163 million in the same period of the previous year. Continued investment in R&D is progressing. - FY2022AdvancedAnnual report
「The current R&D structure in Japan consists of 5 departments under the Development Headquarters: the Applied Development Research Department, Basic Science Research Department, Development Planning Office, Overseas Development Department and Development Administration Department. R&D expenses for the consolidated fiscal year were ¥928 million. R&D expenses in Southeast Asia for the consolidated fiscal year were ¥64 million.」
R&D expenses of ¥928 million in Japan and ¥64 million in Southeast Asia, for a total of ¥993 million, were recognized, up from consolidated R&D expenses of ¥774 million in the previous fiscal year. - FY2022-Q3AdvancedAnnual report
「The amount of R&D activities for the entire group during the third quarter of the current consolidated cumulative period was ¥781 million.」
R&D expenses for the third-quarter cumulative period of ¥781 million were disclosed, indicating continued investment in R&D. - FY2022-Q2AdvancedAnnual report
「The amount of R&D activities for the entire group during the second quarter of the current consolidated cumulative period was ¥469 million.」
R&D expenses for the second-quarter cumulative period of ¥469 million were disclosed, indicating continued investment in R&D. - FY2022-Q1AdvancedAnnual report
「The amount of R&D activities for the entire group during the first quarter of the current consolidated cumulative period was ¥169 million.」
R&D expenses for the first quarter were ¥169 million, up from ¥163 million in the same period of the previous year. - FY2021AdvancedAnnual report
「The current R&D structure in Japan consists of 4 divisions under the Development Headquarters: the Development Research Department, Development Planning Department, Overseas Development Research Department and Development Administration Office. R&D expenses for the consolidated fiscal year were ¥721,183 thousand.」
R&D expenses in Japan were ¥721,183 thousand. Including ¥53,414 thousand in Southeast Asia, consolidated R&D expenses were ¥774,597 thousand. - FY2021-Q3AdvancedAnnual report
「The amount of R&D activities for the entire group during the third quarter of the current consolidated cumulative period was ¥613 million.」
R&D expenses increased from ¥529 million in the same period of the previous year to ¥613 million, reflecting continued investment. - FY2021-Q1AdvancedAnnual report
「The amount of R&D activities for the entire group during the first quarter of the current consolidated cumulative period was ¥163 million.」
R&D expenses increased from ¥155 million in the same period of the previous year to ¥163 million, reflecting continued investment. - FY2020AdvancedAnnual report
「R&D expenses for the consolidated fiscal year were ¥688,396 thousand.」
R&D expenses increased from ¥671,979 thousand in the previous fiscal year to ¥688,396 thousand, reflecting continued investment. - FY2020-Q3AdvancedAnnual report
「The amount of R&D activities for the entire group during the third quarter of the current consolidated cumulative period was ¥529 million.」
R&D investment continued, increasing from ¥525 million in the same period of the previous year to ¥529 million. - FY2020-Q2RestatedAnnual report
「The amount of R&D activities for the entire group during the second quarter of the current consolidated cumulative period was ¥359 million. There were no material changes in the status of the group's R&D activities during the second quarter of the current consolidated cumulative period.」
The company reaffirmed its continued investment in R&D and the absence of material changes in its R&D activities. - FY2020-Q1AdvancedAnnual report
「The amount of R&D activities for the entire group during the first quarter of the current consolidated cumulative period was ¥155 million.」
R&D investment continued, increasing from ¥149 million in the same period of the previous year to ¥155 million. - FY2019AdvancedAnnual report
「R&D expenses for the consolidated fiscal year were ¥671,979 thousand.」
R&D investment continued, increasing from ¥641,578 thousand in the previous period to ¥671,979 thousand. - FY2019-Q3AdvancedAnnual report
「The amount of R&D activities for the entire group during the third quarter of the current consolidated cumulative period was ¥525 million.」
R&D investment continued, increasing from ¥492 million in the same period of the previous year to ¥525 million. - FY2019-Q2RestatedAnnual report
「The amount of R&D activities for the entire group during the second quarter of the current consolidated cumulative period was ¥360 million. There were no material changes in the status of the group's R&D activities during the second quarter of the current consolidated cumulative period.」
The company continued to recognize R&D expenses and reaffirmed that there were no material changes in its R&D activities. - FY2019-Q1RestatedAnnual report
「The amount of R&D activities for the entire group during the first quarter of the current consolidated cumulative period was ¥149 million. There were no material changes in the status of the group's R&D activities during the first quarter of the current consolidated cumulative period.」
The company continued to recognize R&D expenses and reaffirmed that there were no material changes in its R&D activities. - FY2018AdvancedAnnual report
「R&D expenses for the consolidated fiscal year were ¥641,578 thousand.」
R&D investment continued, increasing from ¥567,005 thousand in the previous period to ¥641,578 thousand. - FY2018-Q3RestatedAnnual report
「The amount of R&D activities for the entire group during the third quarter of the current consolidated cumulative period was ¥492 million. There were no material changes in the status of the group's R&D activities during the third quarter of the current consolidated cumulative period.」
R&D expenses continued to be recognized, and the company stated that there were no material changes in its R&D activities. - FY2018-Q2RestatedAnnual report
「The amount of R&D activities for the entire group during the second quarter of the current consolidated cumulative period was ¥253 million. There were no material changes in the status of the group's R&D activities during the second quarter of the current consolidated cumulative period.」
The company continued to recognize R&D expenses and reaffirmed that there were no material changes in its R&D activities. - FY2018-Q1RestatedAnnual report
「The amount of R&D activities for the entire group during the first quarter of the current consolidated cumulative period was ¥118 million. There were no material changes in the status of the group's R&D activities during the first quarter of the current consolidated cumulative period.」
The company continued to recognize R&D expenses and reaffirmed that there were no material changes in its R&D activities. - FY2017-Q3RestatedAnnual report
「The amount of R&D activities for the entire group during the third quarter of the current consolidated cumulative period was ¥437 million. There were no material changes in the status of the group's R&D activities during the third quarter of the current consolidated cumulative period.」
The company reaffirmed its continued investment in R&D and the absence of material changes in its R&D activities. - FY2017-Q2RestatedAnnual report
「The Group’s total research and development expenses for the six-month period ended 30 September amounted to ¥286 million. There were no material changes in the status of the Group’s research and development activities during the six-month period ended 30 September.」
R&D expenses continued to be recognized, and the company stated that there were no material changes in its R&D activities. - FY2017-Q1RestatedAnnual report
「The amount of R&D activities for the entire group during the first quarter of the current consolidated cumulative period was ¥107 million. There were no material changes in the status of the group's R&D activities during the first quarter of the current consolidated cumulative period.」
R&D expenses were recognized in the quarter, and the company stated that there were no material changes in its R&D activities. - FY2016First statedAnnual report
「R&D expenses for the consolidated fiscal year were ¥513,492 thousand.」
R&D activities were conducted in Japan, Southeast Asia and elsewhere, and R&D expenses for the period were disclosed.